Objective: The aim of this study is to understand characteristics and influencing factors of Mycobacterium tuberculosis drug resistance in suburban counties of Hangzhou. Methods: A retrospective study was conducted to collect clinical data (including age, gender, registration time, registered residence, treatment classification, mycobacterium sputum culture, species identification, and drug susceptibility test results (isoniazid, rifampicin, ethambutol, levofloxacin, and moxifloxacin)) from 2456 clinically diagnosed pulmonary tuberculosis patients from designated hospitals in all eight suburban counties of Hangzhou from 2022 to 2024. Single-factor and multivariable logistic regression model were used to analyze the drug resistance characteristics and influencing factors among different populations. Results: In the 2456 isolates of mycobacteria, 2165 (88.15%) of the strains were identified as Mycobacterium tuberculosis complex, and 291 (11.85%) were non-tuberculous mycobacterium; 2254 (91.78%) were initial treatment cases, and 202 (8.22%) were retreatment cases; 1910 (88.22%) were sensitive to all five anti-tuberculosis drugs, while 255 (11.78%) were resistant strains; the total drug resistance, first-line anti-tuberculosis drug resistance, single drug resistance, multiple drug resistance and pre-extensive drug resistance rates were 11.78% (255/2165), 8.36% (181/2165), 6.28% (136/2165), 1.94% (42/2165) and 0.42% (9/2165), respectively. The resistance rate against isoniazid was the highest (7.62%, 165/2165), followed by levofloxacin and moxifloxacin (all 4.02%, 87/2165), rifampicin (2.59%, 56/2165), and ethambutol (1.15%, 25/2165); The drug resistance rates of isoniazid, rifampicin, ethambutol, total and multidrug resistance rates have all significantly decreased compared to the rates of 2017—2019 (10.53% (306/2907), 4.02% (117/2907), 2.03% (59/2907), 14.90% (433/2907), 3.06% (89/2907),χ2=12.431, P=0.005; χ2=7.790, P=0.005; χ2=5.831, P=0.016; χ2=10.281, P=0.001; χ2=6.204, P=0.013). There were a total of 14 patterns of 255 drug-resistant strains, among which 52.94% (135) of the drug-resistant strains were only resistant to one drug, with isoniazid resistance being the main type (45.88%, 117); 37.25% (95) of resistant strains were resistant to two drugs, with levofloxacin+moxifloxacin as the dominant pattern (27.84%, 71), followed by isoniazid+rifampicin pattern (8.24%, 21); Only 5.49% (14) of resistant strains were resistant to three drugs. The total drug resistance rate (highest in Lin’an District (18.62%) and lowest in Linping District (8.99%)), rifampicin resistance rate (highest in Yuhang District (5.47%) and lowest in Chun’an County (0.54%)) and multidrug resistance rate (highest in Yuhang District (5.47%) and lowest in Chun’an County (0.54%)) in 8 suburban counties showed statistically significant differences (χ2=14.556, P=0.042; χ2=17.551, P=0.014; χ2=16.177, P=0.024). The results of multiple logistic regression analysis showed that working in service industry (OR=7.887, 95%CI: 3.046-20.775), being cadres or staff (OR=5.143, 95%CI: 1.385-17.420), retreated patients (OR=3.313, 95%CI: 2.176-4.959), and aged over 60 years old (OR=1.801, 95%CI: 1.029-3.255) were risk factors for developing Mycobacterium tuberculosis drug resistance. Conclusion: The control of drug-resistant Mycobacterium tuberculosis in suburban areas of Hangzhou is generally satisfactory, but it is still necessary to strengthen management and standardized treatment among retreated patients with emphasis on drug resistance screening, and strengthen active tuberculosis screening among service industry workers, cadres and staff and the elderly population, to effectively control the spread of drug-resistant tuberculosis.